Indosia Pharmaceuticals Private Limited
About Indosia Pharmaceuticals Private Limited
Data last updated:
Indosia Pharmaceuticals Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the repair services segment of the electronics sector. It was incorporated on 30 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U52609MH2018PTC317708. Its GSTIN is 27AAFCI0840L1ZI (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Farid Shaikh Hamid Shaikh and Shaikh Asif Shaikh Jalal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Office 273 Satra Plaza Sector 19D Palm Beach Road Vashi Navi Mumbai, Maharashtra, India – 400705.
As per the financials filed for FY 2025, the company reported a revenue of ₹29.77 Lakh, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹1,604 (net margin 0.1%) and EBITDA of ₹30,445 (EBITDA margin 1%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 28% over five years.
Company details
Contact details
Indosia Pharmaceuticals Private Limited's registered office is in Navi Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressOffice 273 Satra Plaza Sector 19D Palm Beach Road Vashi Navi Mumbai, Maharashtra, India – 400705
- IndustryElectrnoics, Repair Services
To see the full contact details of Indosia Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Indosia Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Indosia Pharmaceuticals Private Limited, buy the company report.
Financials of Indosia Pharmaceuticals Private Limited
FY 2024 filings availableIndosia Pharmaceuticals Private Limited reported revenue of ₹29.77 Lakh (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 28%. EBITDA fell 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹30,445 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,604 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Indosia Pharmaceuticals Private Limited, buy the company report.
Board of directors of Indosia Pharmaceuticals Private Limited
Indosia Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Farid Shaikh Hamid Shaikh | Director | 27 Feb 2024 | 2 Years 8 Months | Current |
| Shaikh Asif Shaikh Jalal | Director | 27 Feb 2024 | 2 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Indosia Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Indosia Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Indosia Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCI0840L1ZI | Maharashtra | Active | 09 Jan 2019 |
To see the full GST registrations and return filing status of Indosia Pharmaceuticals Private Limited, buy the company report.
Recent activity
Indosia Pharmaceuticals Private Limited has 6 board changes on record since 2022: 2 appointments and 4 cessations. The latest: Farid Shaikh Hamid Shaikh was appointed as Director on 27 Feb 2024.
Frequently asked questions
Indosia Pharmaceuticals is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in repair services, within the electronics industry. It was incorporated on 30 November 2018 (8+ years old) and is registered under CIN U52609MH2018PTC317708.
Indosia Pharmaceuticals has 2 current directors:
- Farid Shaikh Hamid Shaikh - Director
- Shaikh Asif Shaikh Jalal - Director
The latest financial statements of Indosia Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Indosia Pharmaceuticals is 27AAFCI0840L1ZI, registered in Maharashtra.
The CIN (Corporate Identification Number) of Indosia Pharmaceuticals is U52609MH2018PTC317708. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indosia Pharmaceuticals was incorporated on 30 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Farid Shaikh Hamid Shaikh was appointed as Director on 27 Feb 2024. Pinjari Vasim Shaikh Jalal ceased to be Whole-Time Director on 27 Feb 2024. Shaikh Asif Shaikh Jalal was appointed as Director on 27 Feb 2024. Indosia Pharmaceuticals has 6 board changes on record in total.
The registered office of Indosia Pharmaceuticals is at Office 273 Satra Plaza Sector 19D Palm Beach Road Vashi Navi Mumbai, Maharashtra, India – 400705.
Indosia Pharmaceuticals operates in the electronics industry, in the repair services segment.
Indosia Pharmaceuticals can be reached at its registered office: Office 273 Satra Plaza Sector 19D Palm Beach Road Vashi Navi Mumbai, Maharashtra, India – 400705.